Evidence map›Paper›PMID 38129923›Full record

ArticleStem cell research & therapy2023

Effect of miR-21 in mesenchymal stem cells-derived extracellular vesicles behavior.

Miriam Morente-López, Rocio Mato-Basalo, Sergio Lucio-Gallego, Concha Gil, Mónica Carrera, Juan A Fafián-Labora, Jesús Mateos, María C Arufe

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Miriam Morente-López *Grupo de Terapia Celular y Medicina Regenerativa, Dpto. de Fisioterapia, Medicina y Ciencias Biomédicas. Facultad de Ciencias de la Salud, Universidade da Coruña, INIBIC-CHUAC, CICA, 15006, A Coruña, Spain.
Rocio Mato-Basalo *Grupo de Terapia Celular y Medicina Regenerativa, Dpto. de Fisioterapia, Medicina y Ciencias Biomédicas. Facultad de Ciencias de la Salud, Universidade da Coruña, INIBIC-CHUAC, CICA, 15006, A Coruña, Spain.
Sergio Lucio-GallegoGrupo de Terapia Celular y Medicina Regenerativa, Dpto. de Fisioterapia, Medicina y Ciencias Biomédicas. Facultad de Ciencias de la Salud, Universidade da Coruña, INIBIC-CHUAC, CICA, 15006, A Coruña, Spain.
Concha GilProteomics Facility-Complutense University and Scientific Park Foundation of Madrid, Madrid, Spain.
Mónica CarreraInstitute of Marine Research (IIM), Spanish National Research Council (CSIC), Vigo, Spain.
Juan A Fafián-LaboraGrupo de Terapia Celular y Medicina Regenerativa, Dpto. de Fisioterapia, Medicina y Ciencias Biomédicas. Facultad de Ciencias de la Salud, Universidade da Coruña, INIBIC-CHUAC, CICA, 15006, A Coruña, Spain.
Jesús MateosClinical Pharmacology Group, Health Research Institute of Santiago de Compostela (FIDIS), 15706, Santiago de Compostela, Spain. jesus.mateos.martin@sergas.es.
María C ArufeGrupo de Terapia Celular y Medicina Regenerativa, Dpto. de Fisioterapia, Medicina y Ciencias Biomédicas. Facultad de Ciencias de la Salud, Universidade da Coruña, INIBIC-CHUAC, CICA, 15006, A Coruña, Spain. maria.arufe@udc.es.ORCID 0000-0003-3725-0743
Universidade da Coruña · ESConsejo Superior de Investigaciones Científicas · ESUniversidade de Santiago de Compostela · ES

Funding

Instituto de Salud Carlos III PI20/00497Xunta de Galicia 11_IN858A_2021_1141142Xunta de Galicia ED481D-2021-020.
6 · The paper itself

Abstract

backgroundA challenging new branch of research related to aging-associated diseases is the identification of miRNAs capable of modulating the senescence-associated secretory phenotype (SASP) which characterizes senescent cells and contributes to driving inflammation.

methodsMesenchymal stem cells (MSC) from human umbilical cord stroma were stable modified using lentivirus transduction to inhibit miR-21-5p and shotgun proteomic analysis was performed in the MSC-derived extracellular vesicles (EV) to check the effect of miR-21 inhibition in their protein cargo. Besides, we studied the paracrine effect of those modified extracellular vesicles and also their effect on SASP.

resultsSyndecan-1 (SDC1) was the most decreased protein in MSC-miR21

conclusionThis work demonstrates the importance of miR-21 in inflammaging and its role in SASP through SDC1.

Indexed as

Extracellular VesiclesMesenchymal Stem CellsMicroRNAsHumansInflammationProteomicsMicroRNAsMIRN21 microRNA, humanExtracellular vesicles (EV)InflammagingMesenchymal stem cells (MSC)miR-21-5p (miR-21)Senescence-associated secretory phenotype (SASP)Syndecan-1 (SDC1)

Identifiers

PMID38129923
PMCPMC10740217
OpenAlexW4390061168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.